A terminal deoxyribonucleoside transferase variant and its application
A deoxyribonucleoside and transferase technology, applied in the field of terminal deoxyribonucleoside transferase variants, can solve the problems of low DNA polymerase activity and difficulty in enzymatic oligonucleotides, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Obtaining of TDT protein
[0038] 1. Amino acid sequence of TDT protein
[0039] The wild-type TDT amino acid sequence is SEQ ID NO: 1;
[0040] 2. Construction of expression vector
[0041] All gene sequences that can synthesize the amino acid sequence shown in SEQ ID NO: 1 can be used for the construction of expression vectors, and the gene sequences are constructed into expression vector pET-28a (Novagen, Kan+, see figure 1 )Restriction sites Nde I and xho Between I, obtain recombinant plasmid, named as pET-28a-TDT. pET-28a is described in the examples, but the expression vector of the present invention is not limited thereto.
[0042] 3. gene expression
[0043] In order to detect the activity of TDT enzyme in vitro, the enzyme was expressed and purified exogenously in Escherichia coli. The host bacterium described in the embodiment is E. coli BL21 (DE3).
[0044] (1) Transfer the Escherichia coli expression recombinant plasmid pET-28a-TDT ...
Embodiment 2
[0057] Example 2 Obtaining of Mutants
[0058] Through computer simulation, the substrate molecules and proteins were docked, the catalytic mechanism was analyzed, and the D396E and K403M variants were obtained, and the target variants were introduced by PCR. The expression and purification conditions of the variants are the same as those of the wild-type TDT expression and purification conditions in Example 1.
Embodiment 3
[0059] Example 3 Function Verification
[0060] The nucleotide used in this embodiment is a nucleotide with a phosphate added to the 3'-OH end as a blocking group, and the 5' end has three phosphates.
[0061] 1 . In vitro pure enzyme reaction, the reaction schematic diagram see image 3 .
[0062] 2. TDT reaction system: 100 mM NaCl, 0.25 mM CoCl 2 , 50 mM KAc, 10 mM Mg(Ac) 2 , pH6.8. Substrate: 100 µM oligo (14 bp), 1 µM 3'-modified nucleotides. Enzyme: 0.1 mM TDT wild type and mutants.
[0063] Reaction conditions: Incubate at 35°C for 1 min and immediately add 0.5 M EDTA to terminate the reaction, inactivate at 70°C (to denature the protein and release the oligo chain) and centrifuge to take the supernatant for urea-denatured PAGE gel.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com